[1]
Mazhindu, T. et al. 2026. Doxorubicin-induced early-onset chronic progressive cardiotoxicity, pharmacogenetics and survival among breast cancer patients in Zimbabwe. South African Medical Journal. 116, 5 (Jun. 2026), e3655. DOI:https://doi.org/10.7196/SAMJ.2026.v116i5.3655.